News
1 minute read

MBHB Partner Kevin Noonan Quoted In Article Entitled, “This Court Battle Will Decide Who Will Make a Fortune From Gene-Editing Tech”

McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. is quoted in an April 29, 2018 Bloomberg article entitled, “This Court Battle Will Decide Who Will Make a Fortune From Gene-Editing Tech.” Scientists have used the breakthrough gene-editing technology CRISPR to create advances in medicine and agriculture, from ways to eliminate sickle-cell anemia to growing mushrooms that resist browning. view the article